Financial Results (Standalone)

Quarter Ended 30th September 2026 (Unaudited):

  • Total Income: ₹142.90 lakh (Revenue from operations: ₹142.90 lakh, Other Income: ₹0)
  • Total Expenses: ₹142.37 lakh
  • Employee benefit expense: ₹1.56 lakh
  • Finance costs: ₹0.01 lakh
  • Depreciation and amortization expense: ₹0.80 lakh
  • Other expenses: ₹140.00 lakh
  • Profit before tax: ₹0.53 lakh
  • Tax Expense: ₹0
  • Profit after tax: ₹0.53 lakh
  • Earnings per equity share (Face value ₹10): Basic ₹0.01, Diluted ₹0.01

Half Year Ended 30th September 2026 (Unaudited):

  • Total Income: ₹142.90 lakh
  • Total Expenses: ₹149.79 lakh
  • Loss before tax: ₹6.89 lakh
  • Tax Expense: ₹0
  • Loss after tax: ₹6.89 lakh
  • Earnings per equity share (Face value ₹10): Basic (₹0.19), Diluted (₹0.19)

Comparative Figures:

  • Q2 FY26: Loss after tax of ₹4.12 lakh
  • H1 FY25: Loss after tax of ₹15.57 lakh
  • FY26 (Audited): Loss after tax of ₹49.83 lakh

Capital Structure

  • Paid-up equity share capital (Face value ₹10 each): ₹686.59 lakh as at 30th September 2026 (increased from ₹346.59 lakh as at 31st March 2026)
  • Reserves/Other Equity: Negative ₹361.44 lakh as at 30th September 2026 (negative ₹439.55 lakh as at 31st March 2026)

Assets and Liabilities (Standalone)

As at 30th September 2026:

  • Total Assets: ₹475.80 lakh
  • Non-current assets: ₹77.07 lakh
  • Current assets: ₹398.73 lakh
  • Inventories: ₹235.76 lakh
  • Trade receivables: ₹50.83 lakh
  • Cash and cash equivalents: ₹1.28 lakh
  • Other financial assets: ₹110.54 lakh
  • Other current assets: ₹0.32 lakh
  • Total Equity and Liabilities: ₹475.80 lakh
  • Equity: ₹325.15 lakh
  • Non-current liabilities: ₹129.16 lakh
  • Current liabilities: ₹21.49 lakh

Preferential Issue of Convertible Warrants

First Tranche (₹4.25 crore raised):

  • Date of raising funds: 17-09-2026
  • Amount raised: ₹2,76,25,000
  • Objects: Working Capital Requirement (₹318.75 lakh), General Corporate Purpose (₹106.25 lakh)
  • Utilization: Working Capital (₹207.19 lakh utilized, ₹0 unutilized), General Corporate Purpose (₹69.06 lakh utilized, ₹0 unutilized)
  • No deviations/variations reported

Second Tranche:

  • Date of raising funds: 25-09-2026
  • Amount raised: ₹42,50,000
  • Objects: Working Capital Requirement (₹318.75 lakh), General Corporate Purpose (₹106.25 lakh)
  • Utilization: Working Capital (₹31.87 lakh utilized), General Corporate Purpose (₹9.54 lakh utilized, ₹1.09 lakh unutilized)
  • No deviations/variations reported

Warrant Details:

  • On 26th February 2026, company allotted 34,00,000 Convertible Equity Share Warrants on preferential basis to non-promoter allottees
  • Issue price: ₹12.50 per warrant (Face value ₹10.00 + premium ₹2.50)
  • Received 25% of total issue price (₹1,06,25,000) on 26th February 2026
  • Received remaining 75% (₹3,18,75,000) during the quarter ended September 2026
  • Warrants converted into 34,00,000 equity shares on 25th September 2026
  • New shares rank pari passu with existing equity shares

Auditor's Review Report

  • Statutory Auditor: M/s. V S S B & Associates, Chartered Accountants
  • Review conducted in accordance with SRE 2410
  • Qualified Opinion: Auditors were not provided with balance confirmation or details for trade receivables and trade payables, and are unable to confirm the balance and nature of transactions
  • Except for the qualification, nothing came to attention that causes belief that financial results contain material misstatement

Compliance Statements

  • Financial results prepared in accordance with Indian Accounting Standards (Ind AS) and SEBI LODR Regulations
  • Company operates in a single segment
  • Results reviewed by Audit Committee and taken on record by Board of Directors on 17th October 2026
  • No associates, subsidiaries, or joint ventures
  • No deviations/variations in use of funds from preferential issue
  • Audit Committee comments: None
  • Auditor comments on fund utilization: None

Financial Impact

  • Q2 FY27 shows profit turnaround from loss in previous year
  • Significant increase in share capital due to warrant conversion
  • Negative reserves position
  • Working capital requirements funded through preferential issue proceeds